Top Pharma and Innovative Biotech Presentations at the 2025 Immuno-Oncology Summit
Discover Presentations from industry pioneers, thought leaders, and influencers as they converge to showcase the latest breakthroughs in cancer immunology.
Engineering Antibody-Drug Conjugates for Optimal Payload Delivery in Solid Tumors
Ian Nessler, PhD, Senior Scientist II, Quantitative, Translational, and ADME Sciences, AbbVie
Functional Effects of Cancer Cell Phagocytosis on Tumor Macrophages
Kristin V. Tarbell, PhD, Associate Director, Discovery, Amgen
Women in Science Meet-Up
Amina Metidji, PhD, Senior Scientist, AstraZeneca
Advancing Drug Discovery with Hypoxic 3D Tumor Models
Orna Rabinovich Ernst, PhD, Senior Scientist, R&D, AstraZeneca
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T Cell Exclusion in Human Lung Tumors
Shilpa Keerthivasan, PhD, Associate Director, Immunology, Bristol Myers Squibb
Comparison of Cancer-Targeting and Stromal-Targeting Antibody-Drug Conjugates Using Bystander Quantitative Systems Pharmacology Models
Ezgi Wood, PhD, Associate Director, QSP, Bristol Myers Squibb
Impacts of ADCs on the Immune Response to Cancer
Ryan A. Heiser, PhD, Director Immuno-Oncology, Pfizer